Clinical trials: Liver Failure

Hepatic Insufficiency, Renal Insufficiency

Study of Copanlisib in Hepatic or Renal Impairment

• Completed
• Age: 18 to 80 years
• Phase 1
• Results posted

To evaluate the pharmacokinetics and safety of copanlisib in subjects with impaired hepatic or renal function in comparison to healthy subjects

Trial name

NCT03172884

Testing

Copanlisib (ALIQOPA, BAY80-6946)

Where

2 sites in Germany, Romania

Volunteers

30 people, healthy volunteers welcome

Sponsor

Bayer